Health Status, Quality of Life, Psychosocial Well-being, and Wearables Data of Patients With Active Ulcerative Colitis Receiving Filgotinib Therapy (FilgoColitis Study): Protocol for a Real-world Observational Study

Health Status, Quality of Life, Psychosocial Well-being, and Wearables Data of Patients With Active Ulcerative Colitis Receiving Filgotinib Therapy (FilgoColitis Study): Protocol for a Real-world Observational Study

BackgroundFilgotinib was approved in Germany for treating patients with moderate to severe active ulcerative colitis in November 2021. It represents a preferential Janus kinase 1 inhibitor. The FilgoColitis study began recruiting immediately after approval and aims to assess...

Full description

Bibliographic Details
Main Authors: Sandra Plachta-Danielzik, Lena Grasskemper, Karen Schmidt, Stefan Schreiber, Bernd Bokemeyer
Format: Article
Language:English
Published: JMIR Publications 2023-05-01
Series:JMIR Research Protocols
Online Access:https://www.researchprotocols.org/2023/1/e42574

Internet

https://www.researchprotocols.org/2023/1/e42574

Similar Items